Tag: #Global Trends

Key Development Argenx has agreed to acquire Forte Biosciences in a transaction valued at approximately $2.2 billion, representing one of... Read more

Key Development The European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion recommending marketing... Read more

Key Development The US Food and Drug Administration has approved Outlook Therapeutics' Lytenava for the treatment of wet age related... Read more

Key Development The Democratic Republic of Congo has reported more than 3,000 confirmed Ebola cases, marking a significant milestone in... Read more

Key Development The expanding Cyclospora outbreak in the United States has evolved beyond a routine foodborne illness investigation into a... Read more

Key Development A U.S. Food and Drug Administration (FDA) advisory committee has voted to recommend placing BPC-157 on the agency's... Read more

Key Development Merck has significantly expanded its global access strategy by signing seven voluntary licensing agreements that will allow generic... Read more

Key Development GE HealthCare has announced that Chief Financial Officer Jay Saccaro will step down to pursue an opportunity outside... Read more

Key Development A U.S. federal judge has cast significant doubt on the scientific evidence underpinning approximately 69,000 lawsuits alleging that... Read more